Skip Navigation

A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer mCRPC

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04071236

Study #:
STUDY00146233

Start Date:
Nov 11, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04071236

View Complete Trial Details & Eligibility at ClinicalTrials.gov